The emerging role of PET imaging in dementia
Open Access
- 12 October 2017
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 6, 1830
- https://doi.org/10.12688/f1000research.11603.1
Abstract
A compelling need in the field of neurodegenerative diseases is the development and validation of biomarkers for early identification and differential diagnosis. The availability of positron emission tomography (PET) neuroimaging tools for the assessment of molecular biology and neuropathology has opened new venues in the diagnostic design and the conduction of new clinical trials. PET techniques, allowing the in vivo assessment of brain function and pathology changes, are increasingly showing great potential in supporting clinical diagnosis also in the early and even preclinical phases of dementia. This review will summarize the most recent evidence on fluorine-18 fluorodeoxyglucose-, amyloid -, tau -, and neuroinflammation - PET tools, highlighting strengths and limitations and possible new perspectives in research and clinical applications. Appropriate use of PET tools is crucial for a prompt diagnosis and target evaluation of new developed drugs aimed at slowing or preventing dementia.Keywords
This publication has 147 references indexed in Scilit:
- A European multicentre PET study of fibrillar amyloid in Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Decreased microglial activation in MS patients treated with glatiramer acetateZeitschrift für Neurologie, 2011
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28Journal of Cerebral Blood Flow & Metabolism, 2011
- Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)Journal of Molecular Neuroscience, 2011
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseAnnals of Neurology, 2011
- Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of NeuroinflammationJournal of Cerebral Blood Flow & Metabolism, 2010
- Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimationNeuroImage, 2010
- Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer DiseaseArchives of Neurology, 2009
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004